Class Act

Class Act: Is there clinical evidence for the use of chondroitin sulfate in the treatment of osteoarthritis?

October 17, 2008
Class Act: Is there clinical evidence for the use of chondroitin sulfate in the treatment of osteoarthritis?

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Jillian Borman, MS-4, Reviewed by Svetlana Krasnokutsky, MD, Clinical Instructor, NYU Department of Medicine

Osteoarthritis (OA) is one of the most common causes of joint pain in the aging population. The pain of OA, which is generally worsened with joint use and alleviated with rest, is typically described as a deep…

Read more »

Class Act: The Use of MRI in Breast Cancer Screening

August 28, 2008
Class Act: The Use of MRI in Breast Cancer Screening

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Daniel Green MSIV and Boris Kobrinsky MD, Assistant Professor, NYU Division of Oncology

In 2008, an estimated 182,460 women in the United States will be diagnosed with invasive breast cancer, and 40,480 women will die of the disease as it remains the demographic’s second leading cause of cancer mortality.(1) Fortunately, breast cancer…

Read more »

Class Act: Pathogenesis of Rheumatic Heart Disease

August 14, 2008
Class Act: Pathogenesis of Rheumatic Heart Disease

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Matt Stein MS-4; Reviewed by Harold Horowitz MD, Professor, NYU Division of Infectious Diseases and Immunology

In general, acute rheumatic fever (ARF) is a delayed sequela of a group A streptococcus (GAS) pharyngeal infection. Following an initial throat infection, which is often either untreated or incompletely treated, there exists a latent period of two…

Read more »

Class Act: Polycystic Ovarian Syndrome 2.0

August 1, 2008
Class Act: Polycystic Ovarian Syndrome 2.0

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Marty Wolff MS-4, and Susan Zweig MD, Clinical Instructor, NYU Division of Endocrinology

NH is a 32 year-old obese Hispanic female with a history of…

Read more »

Class Act: What is the risk of microbial keratitis in overnight wear of soft contact lenses?

July 11, 2008
Class Act: What is the risk of microbial keratitis in overnight wear of soft contact lenses?

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Frank Siringo, NYU Medical Student

Soft contact lens wear is the primary risk factor for microbial keratitis, a potentially vision-threatening infection of the cornea, with a…

Read more »

Class Act: The Polypill Panacea

May 1, 2008
Class Act: The Polypill Panacea

Commentary by David Hatcher, MSIII (reviewed by Neil Shapiro, MD Editor-In-Chief, Clinical Correlations)

C.M. is a 68 year-old retired Caucasian male with a past medical history significant for coronary artery disease, hyperlipidemia, HTN, and a 30 pack year history of smoking. His drug regimen consists of a beta-blocker, an ace inhibitor, a statin, and aspirin.

Patients like C.M. are now more common than ever before. He has already had one heart attack, and he has multiple risk factors for…

Read more »

Class Act: Are beta-blockers really contraindicated for patients with a diagnosis of reactive airway disease?

March 21, 2008
Class Act: Are beta-blockers really contraindicated for patients with a diagnosis of reactive airway disease?

Commentary by Katherine Khvilivitzky, NYU Medical Student

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

In the past, reactive airway disease was considered to be a contraindication to administration of all beta-blockers including ophthalmic preparations.…

Read more »

Class Act: Is there clinical evidence for use of probiotics in the treatment of IBS?

March 12, 2008
Class Act: Is there clinical evidence for use of probiotics in the treatment of IBS?

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.

Commentary by Alexander Jow, MSIII

Irritable bowel syndrome (IBS) is a poorly understood disorder, commonly encountered in clinical practice; IBS accounts for more than one-third of…

Read more »

Class Act: Do Statins Always Have to Be Taken in the Evening?

January 10, 2008
Class Act: Do Statins Always Have to Be Taken in the Evening?

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member. Enjoy…

Commentary by David Leaf, MSIV

HMG-CoA reductase inhibitors (statins) are the most powerful drugs used for lowering LDL cholesterol, with median reductions in the range of 30 to 63…

Read more »

Class Act: Relieving the Obstruction – Surgical Approaches to the Management of Obstructive Sleep Apnea

October 18, 2007
Class Act: Relieving the Obstruction – Surgical Approaches to the Management of Obstructive Sleep Apnea

Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member. Enjoy…

Commentary by Andrew Kleinberger, NYU Medical Student

Obstructive Sleep Apnea (OSA) is a syndrome of sleep-disordered breathing that has gained a great deal of attention…

Read more »

Class Act: Is there evidence to support chiropractic care of low back pain?

July 18, 2007
Class Act: Is there evidence to support chiropractic care of low back pain?

Welcome to Class Act, a new feature of Clinical Correlations. Class act will feature posts written by NYU 3rd and 4th year medical students. These posts will focus on evidenced based answers to clinical questions related to patients seen by our students in the clinics or on the wards. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member. Enjoy…

Commentary by Brian Liem, MSIV

A 52 year old male with no medical problems presents to your clinic with a…

Read more »